FDA Adverse Event
Malfunction
Summary report: N
BARRICAID ACD
MDR report key: 15052339
·
Received July 19, 2022
Report
- Report Number
- 3006232063-2022-00001
- Event Type
- Malfunction
- Date Received
- July 19, 2022
- Date of Event
- January 5, 2022
- Report Date
- July 18, 2022
- Manufacturer
- INTRINSIC THERAPEUTICS, INC.
- Product Code
- QES
- PMA / PMN Number
- P160050
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT HAD AN INITIAL IMPLANT OF THE BARRICAID ON (B)(6) 2019. THE PATIENT STARTED EXPERIENCING PAIN ON (B)(6) 2021. RE-OPERATION OCCURRED ON (B)(6) 2022. DURING SURGERY, A PROLAPSE WAS SEEN MEDIAL TO THE POLY MESH OF THE IMPLANT. THE MESH FLIPPED DORSALLY AND PARTIALLY FUSED TO THE DURA/ROOT. ISOLATED EXTRACTION OF THE MESH WAS NOT POSSIBLE. THE ANCHOR REMAINED IN THE VERTEBRAL BODY BECAUSE IT WAS FIRMLY ANCHORED IN THE BONE. AFTER PERFORMANCE OF THE SEQUESTROTOMY THE WOUND WAS CLOSED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 251497 | BARRICAID ACD | BARRICAID | QES | INTRINSIC THERAPEUTICS, INC. | BAR-D8-12X14 | 12041803 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 53 YR | Female | Required Intervention |